AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CVS GROUP PLC

Remuneration Information Oct 7, 2021

7590_rns_2021-10-07_80366708-a9d2-4c5e-88c7-1274d3caacbf.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2761O

CVS Group plc

07 October 2021

6 October 2021

CVS Group Plc

("CVS", the "Company" or the "Group")

Long Term Incentive Plan Awards & PDMR Dealing

CVS, one of the UK's leading providers of integrated veterinary services, announces that it has granted option awards over a total of 74,174 of the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") under the CVS Group Long Term Incentive Plan 2021 ("LTIP 15") (the "Options").  As detailed below, certain of the Options were awarded to the Directors named below, with the balance being issued to certain other employees.

Options awarded to Directors

Name                                    Role                                                       Number of Options

Richard Fairman                Chief Executive Officer                                  21,188  

Ben Jacklin                          Chief Operating Officer                                 12,712

Robin Alfonso                    Chief Financial Officer                                    11,009

The awards will vest in three years' time, subject to certain performance criteria being satisfied.  These vesting criteria relate to the Company's earnings per share growth and total shareholder return over the three-year period between 1 July 2021 and 30 June 2024.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:
CVS Group plc via MHP Communications
Richard Fairman, CEO
Jenny Farrer, Company Secretary
Singer Capital Markets (Nominated Adviser & Broker) +44 20 7496 3000
Aubrey Powell / Jen Boorer / Rachel Hayes
MHP Communications (Financial PR) +44 20 3128 8549
Andrew Jaques / Rachel Mann / Charles Hirst

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fairman

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 0.2 pence each

GB00B2863827

b)

Nature of the transaction

Grant of options under LTIP 15

c)

Price(s) and volume(s)

Price(s) Volume(s)
Exercise price of 0.2p 21,188

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

6 October 2021

f)

Place of the transaction

Off market

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Jacklin

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 0.2 pence each

GB00B2863827

b)

Nature of the transaction

Grant of options under LTIP 15

c)

Price(s) and volume(s)

Price(s) Volume(s)
Exercise price of 0.2p 12,712

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

6 October 2021

f)

Place of the transaction

Off market

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 0.2 pence each

GB00B2863827

b)

Nature of the transaction

Grant of options under LTIP 15

c)

Price(s) and volume(s)

Price(s) Volume(s)
Exercise price of 0.2p 11,009

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

6 October 2021

f)

Place of the transaction

Off market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAPEKEFAFFFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.